Snowflake Partners with Microsoft and OpenAI, Adding Claude and Llama

Snowflake Expands Its Collaboration with Microsoft and OpenAI
Snowflake Inc. (NYSE: SNOW) has announced an exciting enhancement to its partnership with Microsoft Corp. (NASDAQ: MSFT) during a recent earnings call. This update follows an impressive fourth-quarter performance where the company exceeded analyst expectations, showcasing its continued growth and innovation in the data cloud sector.
Introduction of Cortext AI Agents
During the earnings call, Snowflake introduced a new artificial intelligence agent called Cortex, aimed at improving productivity and data access for businesses. This new development signifies a turning point in how organizations utilize data efficiently through advanced AI capabilities.
What Are Cortex Agents?
Cortex Agents are a novel class of AI agents designed to facilitate various business operations using both structured and unstructured data. These agents are set to revolutionize how companies interact with their data, leveraging powerful AI models to deliver actionable insights.
Supporting Leading AI Models
CEO Sridhar Ramaswamy highlighted the integration of multiple market-leading AI models within Cortex, specifically mentioning support for Anthropic’s Claude, Meta's Llama, and DeepSeek. This integration expands Snowflake's capabilities, allowing for greater versatility and function across different data scenarios.
Enhanced Accessibility Through Microsoft Platforms
The partnership also enhances the accessibility of these AI capabilities through Microsoft 365 CoPilot and Microsoft Teams. Ramaswamy conveyed that this effort aims to provide millions of users with seamless access to crucial information, thereby accelerating productivity within the Microsoft ecosystem.
Client Success Stories with Snowflake's Technology
Snowflake has established itself as a vital partner for various prominent organizations. Notably, AstraZeneca PLC (NASDAQ: AZN) is employing Snowflake’s AI and machine learning framework to advance its drug discovery and development processes, aspiring to launch 20 new medicines by the conclusion of this decade.
Investment Insights from State Street Corp.
Additionally, State Street Corp. (NYSE: STT) is harnessing Snowflake's AI capabilities to derive crucial market insights that inform their investment strategies, showcasing the practical implications of Snowflake's technologies on financial decision-making.
Recent Financial Performance
In its recent earnings call, Snowflake reported earnings of 30 cents per share, which is significantly higher than the anticipated 17 cents by analysts. Revenue also showcased remarkable growth, soaring to $986.77 million compared to the forecasted $955.93 million, reflecting a strong year-over-year increase from $774.7 million.
Future Projections
However, it should be noted that Snowflake’s future revenue projections were somewhat lower than analyst forecasts. The company estimates first-quarter revenue to range between $955 million and $960 million, below the sought-after $1 billion threshold. For fiscal 2026, revenue expectations stand at $4.28 billion, which also falls short of the $4.41 billion anticipated by analysts.
Stock Movement and Analyst Ratings
The stock experienced a 1.21% rise on a recent Wednesday and jumped 9.06% during after-hours trading, considerably outperforming the 0.05% gain of the SPDR S&P 500 ETF Trust (NYSE: SPY). Year-to-date, SNOW is up by 5.51% but has witnessed a 28.99% decline over the past year.
Analysts' Outlook
Currently, analysts have rated the stock with a “buy” rating. With 38 analysts tracking Snowflake, the average price target is set at $193.42, with estimates spanning from $121 to $235. Recent evaluations by major firms like Rosenblatt, Citigroup, and Canaccord Genuity yield an average target of $218.33, suggesting prospective growth of approximately 20.46% for investors.
Frequently Asked Questions
1. What are Cortex Agents by Snowflake?
Cortex Agents are advanced AI agents designed to assist businesses in processing and analyzing structured and unstructured data for various applications.
2. How is Snowflake enhancing collaboration with Microsoft?
Snowflake is integrating its AI capabilities into Microsoft tools like 365 CoPilot and Teams to streamline information access and productivity.
3. What financial performance did Snowflake report recently?
Snowflake reported earnings of 30 cents per share and revenue of $986.77 million, surpassing market expectations.
4. What is Snowflake's revenue forecast?
Snowflake anticipates first-quarter revenue to be between $955 million and $960 million, lower than the $1 billion projected by analysts.
5. What do analysts think about Snowflake's stock?
Analysts maintain a “buy” rating on Snowflake stock, with an average price target of $193.42, indicating potential for future growth.
About The Author
Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.